Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
The functional heart is comprised of distinct mesoderm-derived lineages including cardiomyocytes, endothelial cells and vascular smooth muscle cells. Studies in the mouse embryo and the mouse embryonic stem cell differentiation model have provided evidence indicating that these three lineages develop from a common Flk-1(+) (kinase insert domain protein receptor, also known as Kdr) cardiovascular progenitor that represents one of the earliest stages in mesoderm specification to the cardiovascular lineages. To determine whether a comparable progenitor is present during human cardiogenesis, we analysed the development of the cardiovascular lineages in human embryonic stem cell differentiation cultures. Here we show that after induction with combinations of activin A, bone morphogenetic protein 4 (BMP4), basic fibroblast growth factor (bFGF, also known as FGF2), vascular endothelial growth factor (VEGF, also known as VEGFA) and dickkopf homolog 1 (DKK1) in serum-free media, human embryonic-stem-cell-derived embryoid bodies generate a KDR(low)/C-KIT(CD117)(neg) population that displays cardiac, endothelial and vascular smooth muscle potential in vitro and, after transplantation, in vivo. When plated in monolayer cultures, these KDR(low)/C-KIT(neg) cells differentiate to generate populations consisting of greater than 50% contracting cardiomyocytes. Populations derived from the KDR(low)/C-KIT(neg) fraction give rise to colonies that contain all three lineages when plated in methylcellulose cultures. Results from limiting dilution studies and cell-mixing experiments support the interpretation that these colonies are clones, indicating that they develop from a cardiovascular colony-forming cell. Together, these findings identify a human cardiovascular progenitor that defines one of the earliest stages of human cardiac development.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CMs can reliably be derived from human embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) using protocols that involve timed application of GFs or small molecules, that are designed to recapitulate developmental pathways.”
From Cardiovascular disease models: A game changing paradigm in drug discovery and screening (2019) · cites this paper as [148]
Citations
Cites
Laflamme, M. A., Chen, K. Y., Naumova, A. V., Muskheli, V., Fugate, J. A., Dupras, S. K., Reinecke, H., Xu, C., Hassanipour, M., Police, S., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1327 · Cited by 2,206
Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse.
Winnier, G., Blessing, M., Labosky, P. A., & Hogan, B. L. (1995) · Genes & Development · doi:10.1101/gad.9.17.2105 · Cited by 1,788
Cai, C.-L., Liang, X., Shi, Y., Chu, P.-H., Pfaff, S. L., Chen, J., & Evans, S. (2003) · Developmental Cell · doi:10.1016/s1534-5807(03)00363-0 · Cited by 1,610
Moretti, A., Caron, L., Nakano, A., Lam, J. T., Bernshausen, A., Chen, Y., Qyang, Y., Bu, L., Sasaki, M., Martin-Puig, S., et al. (2006) · Cell · doi:10.1016/j.cell.2006.10.029 · Cited by 1,038
Bearzi, C., Rota, M., Hosoda, T., Tillmanns, J., Nascimbene, A., De Angelis, A., Yasuzawa-Amano, S., Trofimova, I., Siggins, R. W., LeCapitaine, N., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706760104 · Cited by 980
Requirement for Wnt3 in vertebrate axis formation
Liu, P., Wakamiya, M., Shea, M. J., Albrecht, U., Behringer, R. R., & Bradley, A. (1999) · Nature Genetics · doi:10.1038/11932 · Cited by 901
Lints, T. J., Parsons, L. M., Hartley, L., Lyons, I., & Harvey, R. P. (1993) · Development · doi:10.1242/dev.119.2.419 · Cited by 861
Conlon, F. L., Lyons, K. M., Takaesu, N., Barth, K. S., Kispert, A., Herrmann, B., & Robertson, E. J. (1994) · Development · doi:10.1242/dev.120.7.1919 · Cited by 770
Kattman, S. J., Huber, T. L., & Keller, G. M. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.10.002 · Cited by 729
Self-citationRole of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum
de la Pompa, J. L., Timmerman, L. A., Takimoto, H., Yoshida, H., Elia, A. J., Samper, E., Potter, J., Wakeham, A., Marengere, L., Langille, B. L., et al. (1998) · Nature · doi:10.1038/32419 · Cited by 660
Cited by
Items 701–800 of 1,000
The role of Sfrp and DKK proteins in cardiomyocyte development
Hsueh, Y., Hodgkinson, C. P., & Gomez, J. A. (2021) · Physiological Reports · doi:10.14814/phy2.14678 · Cited by 24
“Interestingly, the addition of DKK1 before cardiac progenitor cell formation prevents the appearance of cardiomyocytes; mimicking the role of β-catenin inhibition and activation in heart development (Yamashita et al., 2005; Yang et al., 2008).”
BackgroundJiang, C., Goyal, Y., Jain, N., Wang, Q., Truitt, R., Coté, A., Emert, B. L., Mellis, I. A., Kiani, K., Yang, W., et al. (2022) · Genome biology · doi:10.1186/s13059-022-02654-6 · Cited by 26
“Even within clonal cell lines, differentiation outcomes can be highly variable, pointing to a role for non-genetic factors in cell type determination (D’Antonio-Chronowska et al. 2019; Dubois et al. 2011; Volpato et al. 2018; L. Yang et al. 2008; Elorbany et al. 2021).”
BackgroundHeart in a dish – choosing the rightin vitromodel
Drakhlis, L., & Zweigerdt, R. (2023) · Disease Models & Mechanisms · doi:10.1242/dmm.049961 · Cited by 25
“Consequently, to mimic primitive streak and mesoderm induction in vitro , different protocols apply BMP4, activin A and WNT3A (Elliott et al., 2011; Kattman et al., 2011; Laflamme et al., 2007; Yang et al., 2008).”
Yap, L., Chong, L. Y., Tan, C., Adusumalli, S., Seow, M., Guo, J., Cai, Z., Loo, S. J., Lim, E., Tan, R., et al. (2023) · npj Regenerative Medicine · doi:10.1038/s41536-023-00302-6 · Cited by 27
Dierickx, P., Doevendans, P. A., Geijsen, N., & Laake, L. W. V. (2012) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9391-6 · Cited by 29
“This has been shown by isolating a KDR (FLK1/VEGFR2)-positive [122], KDR/PDGFRα-double positive [14], or CXCR4/FLK1double positive cardiac progenitor cell population [156, 157].”
BackgroundMethodAwasthi, S., Matthews, D. L., Li, R. A., Chiamvimonvat, N., Lieu, D. K., & Chan, J. W. (2011) · Journal of Biophotonics · doi:10.1002/jbio.201100077 · Cited by 24
Lewis, F., Henning, B. J., Marazzi, G., Sassoon, D. A., Ellison, G. M., & Nadal‐Ginard, B. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2013-0174 · Cited by 24
Pekkanen-Mattila, M., Ojala, M., Kerkelä, E., Rajala, K., Skottman, H., & Aalto‐Setälä, K. (2012) · Stem Cells International · doi:10.1155/2012/875059 · Cited by 26
“Further, the ability of hFF to maintain pluripotency of stem cells originally cultured on MEF was quite poor.”
BackgroundBan, K., Wile, B. M., Cho, K.-W., Kim, S., Song, M.-K., Kim, S. Y., Singer, J., Syed, A., Yu, S. P., Wagner, M. B., et al. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.10.021 · Cited by 24
“…capacity, embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs), collectively called pluripotent stem cells (PSCs), have emerged as a highly promising and renewable source for generating CMs (Kehat et al., 2001; Laflamme et al., 2007; Yang et al., 2008; Zwi et al., 2009).”
Role of Cdx factors in early mesodermal fate decisions
Foley, T., Hess, B. L., Savory, J. G. A., Ringuette, R., & Lohnes, D. (2019) · Development · doi:10.1242/dev.170498 · Cited by 24
Lodrini, A. M., Barile, L., Rocchetti, M., & Altomare, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020507 · Cited by 28
“A similar protocol uses factors that activate the canonical Wnt/β-catenin signaling pathway instead of BMP/Activin A to induce cardiac mesoderm [76–78]; this methodology has been described to produce up to 50% CMs [79].”
MethodExpression dynamics of HAND1/2 in in vitro human cardiomyocyte differentiation
Okubo, C., Narita, M., Inagaki, A., Nishikawa, M., Hotta, A., Yamanaka, S., & Yoshida, Y. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.06.014 · Cited by 28
“done as reported previously, with some modification (Funakoshi et al., 2016; Yang et al., 2008).”
MethodStem Cell Therapy for Ischemic Heart Disease
Jameel, M. N., & Zhang, J. J. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3434 · Cited by 24
Yodmuang, S., Marolt, D., Marcos-Campos, I., Gadjanski, I., & Vunjak‐Novakovic, G. (2015) · Stem Cell Reviews and Reports · doi:10.1007/s12015-015-9584-x · Cited by 24
“Embryoid Body and Pellet Dissociation The EBs and chondrogenic pellets (at week 1) were dissociated into single cells [24].”
de Peppo, G. M., & Marolt, D. (2012) · Journal of Blood Transfusion · doi:10.1155/2012/317632 · Cited by 27
“Examples of specific lineages derived from hESC using directed differentiation approach include functional motor neurons [68, 69], human cardiovascular progenitors [70], pancreatic endoderm [71], insulin-secreting β-cells [72], hepatocytes [73], and others.”
BackgroundHUH site-specific recombinases for targeted modification of the human genome
González-Prieto, C., Agúndez, L., Linden, R. M., & Llosa, M. (2013) · Trends in biotechnology · doi:10.1016/j.tibtech.2013.02.002 · Cited by 25
Self-citationCardiac differentiation of human pluripotent stem cells
Jiang, J., Han, P., Zhang, Q., Zhao, J.-M., & Ma, Y. (2012) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2012.01528.x · Cited by 23
Vascular smooth muscle cell differentiation from human stem/progenitor cells
Steinbach, S. K., & Husain, M. (2015) · Methods · doi:10.1016/j.ymeth.2015.12.004 · Cited by 23
Song, L., Ahmed, M. F., Li, Y., Bejoy, J., Zeng, C., & Li, Y. (2017) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2017.0307 · Cited by 23
Induction of Human Induced Pluripotent Stem Cells to Cardiomyocytes Using Embryoid Bodies
Hatani, T., Miki, K., & Yoshida, Y. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8597-5_6 · Cited by 24
Jeziorowska, D., Korniat, A., Salem, J., Fish, K. M., & Hulot, J. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1064109 · Cited by 24
“In vitro cardiomyocyte differentiation indeed mimics the process of cardiogenesis in vivo [6] with the initial induction of mesoderm and then of cardiac precursors.”
BackgroundCardiac origin of smooth muscle cells in the inflow tract
Nakano, H., Williams, E. S., Hoshijima, M., Sasaki, M., Minamisawa, S., Chien, K. R., & Nakano, A. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.10.009 · Cited by 23
“Whereas three major cardiovascular lineages can arise from Flk1+/Bry+ mesodermal progenitors [1,4] and Flk1+/Isl1+/Nkx2.”
BackgroundWunderlich, S., Haase, A., Merkert, S., Beier, J., Schwanke, K., Schambach, A., Glage, S., Göhring, G., Curnow, E. C., & Martin, U. (2012) · Cellular Reprogramming · doi:10.1089/cell.2012.0041 · Cited by 23
“…B27 stock solution [50 · ), 1% nonessential amino acid stock, 1 mM Lglutamine, 0.1 mM b-mercapthoethanol (all Invitrogen), and 50 ng/mL bFGF (from the Institute for Technical Chemistry, Leibniz University Hannover)] (Haase et al., 2009; Knoerzer et al., 1989; Liu et al., 2006; Yang et al., 2008).”
BackgroundInfluentialLiu, S., Fang, C., Zhong, C., Li, J., & Xiao, Q. (2023) · Cell Biology and Toxicology · doi:10.1007/s10565-023-09835-4 · Cited by 22
Biomarkers of Human Pluripotent Stem Cell-Derived Cardiac Lineages
Skelton, R. J. P., Kamp, T. J., Elliott, D. A., & Ardehali, R. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.05.001 · Cited by 24
Xuan, W., Wang, Y., Tang, Y., Ali, A. W., Hu, H., Maienschein‐Cline, M., & Ashraf, M. (2018) · Shock · doi:10.1097/shk.0000000000001133 · Cited by 22
“Moreover, transplantation of CPCs derived from hiPSCs and murine iPSCs more effectively improved cardiac function compared with iPSCs-CMs (7, 8).”
BackgroundIsolation and Functional Characterization of Pluripotent Stem Cell–Derived Cardiac Progenitor Cells
Huang, X., & Wu, S. M. (2010) · Current Protocols in Stem Cell Biology · doi:10.1002/9780470151808.sc01f10s14 · Cited by 22
“While a number of cardiac stem/progenitor cell populations from mouse and human ES cells have been described (Moretti et al., 2006, Kattman et al., 2006, Yang et al., 2008, Bu et al., 2009, Domian et al., 2009), the biological relationships between these cell populations remain to be clarified.”
BackgroundSofla, A. Y. N., Cirkovic, B. A., Hsieh, A., Miklas, J. W., Filipović, N., & Radisic, M. (2013) · Biomicrofluidics · doi:10.1063/1.4791649 · Cited by 22
Molecular physiology of cardiac regeneration
Bolli, P., & Chaudhry, H. W. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05814.x · Cited by 22
Heart Regeneration with Embryonic Cardiac Progenitor Cells and Cardiac Tissue Engineering
Tian, S., Ma, P. X., Wang, Z., Liu, Q., & Gnatovskiy, L. (2015) · Journal of Stem Cell and Transplantation Biology · doi:10.19104/jstb.2015.104 · Cited by 24
From Ontogenesis to Regeneration
Chimenti, I., Forte, E., Angelini, F., Giacomello, A., & Messina, E. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-398459-3.00005-8 · Cited by 24
Bylund, J. B., Trinh, L. T., Awgulewitsch, C. P., Paik, D. T., Jetter, C. S., Jha, R., Zhang, J., Nolan, K., Xu, C., Thompson, T. B., et al. (2017) · Stem Cells and Development · doi:10.1089/scd.2016.0226 · Cited by 23
Cardiomyocytes Derived from Human CardiopoieticAmniotic Fluids
Baldassarre, A. D., D’Amico, M. A., Izzicupo, P., Gaggi, G., Guarnieri, S., Mariggiò, M. A., Antonucci, I., Corneo, B., Sirabella, D., Stuppia, L., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-30537-z · Cited by 22
Greenberg, M. J., Daily, N., Wang, A., Conway, M. K., & Wakatsuki, T. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00120 · Cited by 24
“Several methods have been developed to increase the efficiency of differentiation of stem cells to hPSCCMs in both embryoid bodies (72, 73) and adherent monolayers of cells (74, 75).”
MethodWang, D., Wang, Y., Liu, H., Tong, C., Ying, Q., Sachinidis, A., Li, L., & Peng, L. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14264 · Cited by 23
Doss, M. X., Gaspar, J. A., Winkler, J., Hescheler, J., Schulz, H., & Sachinidis, A. (2011) · Stem Cell Reviews and Reports · doi:10.1007/s12015-011-9263-5 · Cited by 28
“scripts is provided in supplementary Table 1, worksheet 8). It has been shown that endothelial cells, cardiac cells and SMCs originate from common multipotent precursors, either the Isl1 + Progenitor Cells [28] or the KDR + C-KIT (CD117) neg cells [ 29 ].”
BackgroundShe, T., Wang, X., Gan, Y., Kuang, D., Yue, J., Ni, J., ZHAO, X., & Wang, G. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.1125 · Cited by 23
“Increasing evidence indicates that recruitment or direct injection of stem or progenitor cells could participate in the regeneration of heart tissue and improve cardiac function (3-5).”
The integrative aspects of cardiac physiology and their implications for cell‐based therapy
Pijnappels, D. A., Grégoire, S., & Wu, S. M. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05077.x · Cited by 28
Nelson, A. Z., Wang, Y., Wang, Y., Margotta, A. S., Sammler, R. L., Izmitli, A., Katz, J. S., Curtis-Fisk, J. L., Li, Y., & Ewoldt, R. H. (2022) · Soft Matter · doi:10.1039/d1sm01711j · Cited by 21
Medicinal Chemistry Approaches to Heart Regeneration
Schade, D., & Plowright, A. T. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00446 · Cited by 26
Kolanowski, T. J., Rozwadowska, N., Malcher, A., Szymczyk, E., Kasprzak, J. D., Miętkiewski, T., & Kurpisz, M. K. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.02.009 · Cited by 22
“Numerous stem-cell types have been examined to improve an injured heart's function [1–5]; however, the effects of the”
BackgroundChelluri, L. K., Verma, V. K., Kamaraju, S. R., Kancherla, R., Kona, L. K., Beevi, S. S., Debnath, T., Shalini, P. U., Arbab, S. A., & Vadapalli, R. M. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s75445 · Cited by 24
Discrete Logic Modelling Optimization to Contextualize Prior Knowledge Networks Using PRUNET
Sánchez-Archidona, A. R., Crespo, I., Fournier, A., & del Sol, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127216 · Cited by 25
The Future of Induced Pluripotent Stem Cells for Cardiac Therapy and Drug Development
Thorrez, L., & Sampaolesi, M. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211797904154 · Cited by 24
Geraets, I. M. E., Chanda, D., van Tienen, F. H. J., van den Wijngaard, A., Kamps, R., Neumann, D., Liu, Y., Glatz, J. F. C., Luiken, J. J. F. P., & Nabben, M. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.12.025 · Cited by 23
Kamdar, F. D., Kamdar, A. K., Koyano‐Nakagawa, N., Garry, M. G., & Garry, D. J. (2015) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2015.04.010 · Cited by 22
“The current understanding of embryonic cardiac development and differentiation of embryonic stem cells has been applied to the development of several differentiation protocols that reliably direct hiPSCs to the cardiac lineage [9-12].”
Aguilar, J. S., Begum, A. N., Alvarez, J., Zhang, X., Hong, Y., & Hao, J. (2015) · Biochemical Journal · doi:10.1042/bj20150186 · Cited by 23
Ovchinnikov, D. A., Hidalgo, A., Yang, S., Zhang, X., Hudson, J. E., Mazzone, S. B., Chen, C., Cooper-White, J. J., & Wolvetang, E. J. (2014) · Stem Cells and Development · doi:10.1089/scd.2014.0195 · Cited by 22
Myocardial regeneration of the failing heart
Akhmedov, A. T., & Marín-García, J. (2012) · Heart Failure Reviews · doi:10.1007/s10741-012-9348-5 · Cited by 21
“These methods relay on dosedependent exposure to various growth and cardiopoietic factors, including activin, nodal, bone morphogenic proteins (BMPs), fibroblast growth factors (FGFs) and the Wnt proteins [63, 85–89].”
BackgroundMethodIzadifar, M., Kelly, M., & Chen, D. (2014) · Cardiovascular Engineering and Technology · doi:10.1007/s13239-014-0193-7 · Cited by 22
He, P., Fu, J., & Wang, D. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.02.026 · Cited by 20
Efficient Differentiation of Cardiomyocytes from Human Pluripotent Stem Cells with Growth Factors
Jha, R., Xu, R., & Xu, C. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2572-8_9 · Cited by 20
“Wnt3a added during early stage of differentiation and DKK1 during late stage of differentiation) have been found to promote cardiomyocyte differentiation from hPSCs (8-14).”
BackgroundAtmanli, A., & Domian, I. J. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.11.010 · Cited by 21
“Other efforts at directed stem cell differentiation to the cardiac lineage relies on the generation of three-dimensional (3D) constructs called embryoid bodies (EBs) and their treatment with a staged program of signaling molecules including BMP4, bFGF, Activin A, and VEGF among others [16].”
BackgroundTan, X., Dai, Q., Guo, T., Xu, J., & Dai, Q. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.12.007 · Cited by 21
Implications of the Wilms’ Tumor Suppressor Wt1 in Cardiomyocyte Differentiation
Wagner, N., Ninkov, M., Vukolic, A., Deniz, G. Ç., Rassoulzadegan, M., Michiels, J., & Wagner, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094346 · Cited by 21
“Kdr and Pdgfra represent factors, which are involved in cardiomyocyte differentiation, but not limited to cardiomyocyte progenitors [60,61].”
BackgroundNaumova, N., & Iop, L. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.673477 · Cited by 24
“It includes experimental tactics of embryoid body development (Yang et al., 2008) or monolayer attachment culture with specific biochemical conditioning (Laflamme et al., 2007).”
BackgroundMethodSignaling pathways in early cardiac development
Liu, W., & Foley, A. C. (2010) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.112 · Cited by 24
Cardiomyogenic differentiation is fine-tuned by differential mRNA association with polysomes
Pereira, I. T., Spangenberg, L., Robert, A. W., Amorín, R., Stimamiglio, M. A., Naya, H., & Dallagiovanna, B. (2019) · BMC Genomics · doi:10.1186/s12864-019-5550-3 · Cited by 22
“differentiation The hES-NKX2–5 reporter human embryonic stem cell (hESC) line [27] was used to derive cardiomyocytes using a developmentally staged protocol [2, 28] that includes the induction of a cardiac mesoderm population on days 3 and 4 and a NKX2–5/cTNT population by day 15 (Fig.”
MethodGeneration of Heart Organoids Modeling Early Human Cardiac Development Under Defined ConditionsPreprint
Lewis‐Israeli, Y. R., Gabalski, M. A., Ball, K., Wasserman, A. H., Zou, J., Ni, G., Zhou, C., & Aguirre, A. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3654622 · Cited by 23
Reawakening Atlas: Chemical Approaches To Repair or Replace Dysfunctional Musculature
Jung, D., & Williams, D. R. (2012) · ACS Chemical Biology · doi:10.1021/cb3003368 · Cited by 21
The TGFβ superfamily in cardiac dysfunction
Wu, J., Jackson‐Weaver, O., & Xu, J. (2018) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmy007 · Cited by 20
Trillhaase, A., Märtens, M., Aherrahrou, Z., & Erdmann, J. (2021) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10149-3 · Cited by 19
Kim, Y. J., Tamadon, A., Kim, Y. Y., Kang, B.-C., & Ku, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168599 · Cited by 20
“3D EB formation RPMI 1640 + human serum albumin, phosphoascorbate, ITS, lipid mix, Y-27632, DS-I-7 [12] EB formation RPMI1640 + B27 + CHIR99021 [13] EB formation KO-DMEM + 20% FBS (+DMSO) [19] EB formation KO-DMEM + 20% FBS (+DMSO) [16] EB formation Stempro34 w/Activin A, BMP4, bFGF, VEGF, DKK1 [20] EB formation KO DM…”
Multi-electrode monitoring of guided excitation in patterned cardiomyocytes
Wang, L., Liu, L., Li, X., Magome, N., Игоревич, А. К., & Chen, Y. (2012) · Microelectronic Engineering · doi:10.1016/j.mee.2012.11.018 · Cited by 21
Rodrigues, G., Matos, A. F. S., Fernandes, T. G., Rodrigues, C. A. V., Peitz, M., Haupt, S., Diogo, M. M., Brüstle, O., & Cabral, J. M. S. (2013) · Stem Cell Reviews and Reports · doi:10.1007/s12015-013-9482-z · Cited by 23
“Current differentiation protocols are able to derive clinically relevant cell populations, such as dopaminergic neurons [9], cardiomyocytes [10] and insulinproducing cells [11], from hPSCs.”
BackgroundAmniotic membrane as novel scaffold for human iPSC-derived cardiomyogenesis
Parveen, S., Singh, S. P., Panicker, M. M., & Gupta, P. K. (2019) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-019-00321-y · Cited by 21
Jin, G., Li, W., Song, F., Zhao, J., Wang, M., Liu, Q., Li, A., Huang, G., & Xu, F. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.04.010 · Cited by 19
Formation of vascular network structures within cardiac cell sheets from mouse embryonic stem cells
Masuda, S., Matsuura, K., Anazawa, M., Iwamiya, T., Shimizu, T., & Okano, T. (2015) · Regenerative Therapy · doi:10.1016/j.reth.2015.10.002 · Cited by 20
Tang, Y., Hong, Y., Bai, H., Wu, Q., Chen, C. D., Lang, J., Boheler, K. R., & Yang, H. (2016) · Stem Cells · doi:10.1002/stem.2333 · Cited by 20
Onwuka, E. A., King, N., Heuer, E. D., & Breuer, C. K. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a031922 · Cited by 20
“Because of improving technologies, it is becoming more feasible to differentiate pluripotent stem cells, such as ESCs or induced pluripotent stem cells (iPSCs) into cardiomyocytes and to expand them to sufficient numbers to support the diseased myocardium.”
BackgroundInfluentialPolysome profiling followed by RNA-seq of cardiac differentiation stages in hESCs
Pereira, I. T., Spangenberg, L., Robert, A. W., Amorín, R., Stimamiglio, M. A., Naya, H., & Dallagiovanna, B. (2018) · Scientific Data · doi:10.1038/sdata.2018.287 · Cited by 22
Harnessing mechanobiology for kidney organoid research
Nauryzgaliyeva, Z., Corredera, I. G., Garreta, E., & Montserrat, N. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1273923 · Cited by 18
“…two dimensional culture conditions (La fl amme et al., 2007), seminal studies started to address these questions making use of embryoid bodies (EBs) as surrogates of differentiation and cell speci fi cation along the three germ lineages of the human embryo (Yang et al., 2008; Chambers et al., 2009).”
BackgroundSalick, M. R., Napiwocki, B. N., Kruepke, R. A., Knight, G. T., Ashton, R. S., & Crone, W. C. (2020) · Journal of Applied Physics · doi:10.1063/1.5129347 · Cited by 20
Dissecting the Complexity of Early Heart Progenitor Cells
Sendra, M., Dominguez, J. N., Torres, M., & Ocaña, O. H. (2021) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9010005 · Cited by 19
Gao, J., Makiyama, T., Yamamoto, Y., Kobayashi, T., Aoki, H., Maurissen, T. L., Wuriyanghai, Y., Kashiwa, A., Imamura, T., Aizawa, T., et al. (2023) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.122.011387 · Cited by 20
Yamauchi, K., Sumi, T., Minami, I., Otsuji, T. G., Kawase, E., Nakatsuji, N., & Suemori, H. (2010) · Genes to Cells · doi:10.1111/j.1365-2443.2010.01455.x · Cited by 18
“Indeed, addition of an inhibitor of Wnt ⁄b-catenin signaling, such as DKK1, is reported to enhance the generation of cardiomyocytes in hESCs (Yang et al. 2008).”
BackgroundGrajales, L., García, J., & Geenen, D. L. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.06.003 · Cited by 18
“A number of investigators [20, 21] have shown cardiac-like induction in embryonic stem cells when BMP4 and Activin are added to the media.”
BackgroundMethodShinozawa, T., Furukawa, H., Sato, E., & Takami, K. (2012) · SLAS DISCOVERY · doi:10.1177/1087057111434145 · Cited by 20
“Differentiation of hiPSCs was induced as previously described with slight modifications.(17) Briefly, the colonies of hiPSCs were isolated in dissociation solution (ReproCELL), and they formed EBs in suspension culture in low-cell-binding 90-mm dishes (Nunc) in basic medium (StemPro34; Invitrogen, Carlsbad, CA), conta…”
MethodIsolation of Cardiovascular Precursor Cells from the Human Fetal Heart
Gonzales, C., Ullrich, N. D., Gerber, S., Berthonneche, C., Niggli, E., & Pedrazzini, T. (2011) · Tissue Engineering Part A · doi:10.1089/ten.tea.2011.0022 · Cited by 18
“cardiovascular precursors obtained after induction of differentiation in ES cells generated intermediate cells coexpressing cardiac troponin T and SMA and ultimately cardiomyocytes and SMCs.(19) When injected into the mouse heart, Nkx2.”
BackgroundInfluentialCharacterisation and cardiac directed differentiation of canine adult cardiac stem cells
Hodgkiss‐Geere, H., Argyle, D. J., CORCORAN, B. M., Whitelaw, B., Milne, E., Bennett, D., & Argyle, S. A. (2011) · The Veterinary Journal · doi:10.1016/j.tvjl.2010.12.033 · Cited by 18
“Yang et al. (2008) isolated flk-1 positive, c-kit negative stem cell populations from the human heart which gave rise to colonies which contained all three cardiac lineages.”
BackgroundStem Cells and Somatic Cells: Reprogramming and Plasticity
Estrov, Z. E. (2009) · Clinical Lymphoma & Myeloma · doi:10.3816/clm.2009.s.031 · Cited by 21
Dolatshad, N. F., Hellen, N., Jabbour, R. J., Harding, S. E., & Földes, G. (2015) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2015.00076 · Cited by 20
“GPCR Wnt signaling molecules and non-GPCR fibroblast growth factor (FGF), bone morphogenetic protein 4 (BMP4) and Activin A are all widely used for cardiomyocyte differentiation (Laflamme et al., 2007; Yang et al., 2008).”
BackgroundYY1 Expression Is Sufficient for the Maintenance of Cardiac Progenitor Cell State
Grégoire, S., Li, G., Sturzu, A. C., Schwartz, R. J., & Wu, S. M. (2017) · Stem Cells · doi:10.1002/stem.2646 · Cited by 18
Liu, J., Li, Y., Lin, B., Sheng, Y., & Yang, L. (2017) · Developmental Cell · doi:10.1016/j.devcel.2017.10.026 · Cited by 22
Self-citationGet With the (Re)Program: Cardiovascular Potential of Skin-Derived Induced Pluripotent Stem Cells
Tulloch, N. L., Pabon, L., & Murry, C. E. (2008) · Circulation · doi:10.1161/circulationaha.108.791442 · Cited by 18
Generating a self-organizing kidney from pluripotent cells
Little, M. H., & Takasato, M. (2015) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000174 · Cited by 18
Signaling Pathways Governing Cardiomyocyte Differentiation
Mensah, I. K., & Gowher, H. (2024) · Genes · doi:10.3390/genes15060798 · Cited by 18
“Some of these methods include the treatment of stem cells with Activin A, BMP4, bFGF, VEGF, and Dkk-1 to enhance the yield and purity of cardiomyocytes generated from stem cells [168–171].”
MethodDe-Risking Drug Discovery with ADDME — A voiding D rug D evelopment M istakes E arly
Tsaioun, K., & Jacewicz, M. S. (2009) · Alternatives to Laboratory Animals · doi:10.1177/026119290903701s10 · Cited by 19
Laposa, R. R. (2011) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31821823f5 · Cited by 17
“The human heart is composed primarily of mesoderm-derived lineages, including cardiomyocytes, endothelial cells, and vascular smooth muscle cells.(4) There are currently 2 main types of hPSCs: human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs), discussed below.”
BackgroundMechanisms for Progenitor Cell-Mediated Repair for Ischemic Heart Injury
Li, S. C., Acevedo, J., Wang, L., Jiang, H., Luo, J., Pestell, R. G., Loudon, W. G., & Chang, A. C. (2012) · Current Stem Cell Research & Therapy · doi:10.2174/157488812798483449 · Cited by 17
“After hESCs were cultured with a cocktail of many growth factors, embryoid bodies were made which resulted in KDR low/c-kit-(CD117) negative population that displayed cardiac, endothelial and vascular smooth muscle properties in vitro and in vivo [144].”
MethodStem cells as therapy for cardiac disease — a review
Jezierska‐Woźniak, K., Mystkowska, D., Tutas, A., & Jurkowski, M. K. (2011) · Folia Histochemica et Cytobiologica · doi:10.5603/fhc.2011.0004 · Cited by 22
Dental stem cells as an alternative source for cardiac regeneration
Loo, Z. X., Govindasamy, V., Musa, S., & Kasim, N. H. A. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.07.032 · Cited by 18
Generation of Cardiomyocytes from Pluripotent Stem Cells
Nakahama, H., & Pasquale, E. D. (2014) · Methods in molecular biology · doi:10.1007/7651_2014_173 · Cited by 18
Yamauchi, K., Li, J., Morikawa, K., Liu, L., Shirayoshi, Y., Nakatsuji, N., Elliott, D. A., Hisatome, I., & Suemori, H. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.11.133 · Cited by 21
Jiang, Y., Chen, M., Zhang, N., Yang, H.-J., Rui, Q., & Zhou, Y. (2017) · Biology Open · doi:10.1242/bio.029157 · Cited by 25
“We used a serum-free, chemically defined medium with activin A, bFGF, BMP4, DKK-1 and VEGF supplements using a directional differentiation protocol to obtain cardiomyocytes in the stage-specific manner described previously (Kattman et al., 2006; Yang et al., 2008).”
BackgroundMethodYu, M. S., Spiering, S., & Colas, A. R. (2018) · Journal of Visualized Experiments · doi:10.3791/57688 · Cited by 17
Ibarra‐Ibarra, B. R., Franco, M., Páez, A., Varela-López, E., & Massó, F. (2019) · Stem Cells International · doi:10.1155/2019/8940365 · Cited by 17
Jahn, S. K., Hennicke, T., Kassack, M. U., Drews, L., Reichert, A. S., & Fritz, G. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2020.118711 · Cited by 18
Zeng, J., Yi, D., Sun, W., Liu, Y., Chang, J., Zhu, L., Zhang, Y., Pan, X., Dong, Y., Zhou, Y., et al. (2021) · Cell Regeneration · doi:10.1186/s13619-020-00066-0 · Cited by 17
“This indicated that KDR+ cells at a late stage of mesoderm induction could be induced to undergo hematopoietic differentiation by overexpression of HOXA9 (Yang et al. 2008; Brumatti et al. 2013).”
BackgroundAdhesion GPCR Latrophilin-2 Specifies Cardiac Lineage Commitment through CDK5, Src, and P38MAPK
Lee, C.-S., Cho, H., Lee, J. W., Son, H., Chai, J., & Kim, H.-S. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.03.003 · Cited by 17
Metadata
- Authors
- Yang, L., Soonpaa, M. H., Adler, E. D., Roepke, T. K., Kattman, S. J., Kennedy, M., Henckaerts, E., Bonham, K., Abbott, G. W., Linden, R. M., Field, L. J., & Keller, G. M.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- Indiana University School of Medicine (US)
- Cornell University (US)
- University Health Network (CA)
- King's College London (GB)
- VistaGen Therapeutics (United States) (US)
- Corresponding author
- Keller, Gordon M.
- ORCID
- Venue
- Nature
- Published
- 2008-04-23
- Volume
- 453
- Issue
- 7194
- Pages
- 524-528
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2010417854
- Cited by
- 1,389
- References
- 30
- Citations by year
- 2026: 17 · 2025: 20 · 2024: 20 · 2023: 33 · 2022: 45 · 2021: 60 · 2020: 65 · 2019: 59 · 2018: 66 · 2017: 89 · 2016: 79 · 2015: 107 · 2014: 114 · 2013: 141 · 2012: 146
- FWCI
- 45.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Lirias (submittedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL079275, R01HL083126)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- human embryonic stem cells, cardiac progenitor cells, KDR, Flk-1, cardiomyocyte differentiation, endothelial differentiation, vascular smooth muscle cell differentiation, mesoderm specification, heart development, embryoid bodies, cell transplantation, cardiac regeneration, cardiovascular tissue engineering, lineage tracing, clonal origin, growth factor cocktail, activin A, BMP4, basic fibroblast growth factor
- MeSH terms
- Cell Differentiation, Cell Line, Humans, Fibroblast Growth Factor 2, Patch-Clamp Techniques, Proto-Oncogene Proteins c-kit, Cell Lineage, Bone Morphogenetic Proteins, Activins, Myocytes, Cardiac, Intercellular Signaling Peptides and Proteins, Vascular Endothelial Growth Factor Receptor-2, Vascular Endothelial Growth Factor A, Embryonic Stem Cells, Bone Morphogenetic Protein 4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.